Compositions and methods for treating surgical adhesions

Overview

Information

Number
6689803
Application
10/067467
Filing date
02/05/2002
Issue date
02/10/2004
Inventor(s)
William L. Hunter
US Classification
514/365
View at USPTO

Citations

Sanofi-aventis (10)
ALABAMA AT BIRMINGHAM, UNIVERSITY OF (5)
Bristol-Myers Squibb (5)
IPXMEDICAL, LLC (4)
Angiotech International (4)
Poly-Med (4)
NA (3)
Regents of the University of California, The (3)
Merrell Dow Pharmaceuticals (3)
The Johns Hopkins University (2)
The United States of America as represented by the Department of Health (2)
Pfizer (2)
Eisai Co. (2)
Children's Medical Center (2)
Thomas Jefferson University (2)
UNITED STATES OF AMERICA, THE, AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (2)
Massachusetts Institute Of Technology (2)
SPEED GEL (1)
Tapestry Pharmaceuticals (1)
McGill University (1)
Vertex Pharmaceuticals (1)
AMO UPPSALA AB (1)
Phanos Technologies (1)
Vestar (1)
Advanced cardiovascular Systems (1)
PG-TXL (1)
COVALON technology (1)
Matrix Pharmaceutical (1)
Rhone-Poulenc Rorer (1)
Hospira (1)
Celgene (1)
COOK MEDICAL TECHNOLOGIES (1)
Chimerix (1)
HOSTETLER, KARL Y. (1)
Procter & Gamble (1)
Regents Of The University of Minnesota (1)
Chemex Pharmaceuticals (1)
ANGIODEVICE INTERNATIONAL (1)
Montana State University (1)
HOSTETLER FAMILY TRUST (1)

Abstract

Abstract

Methods and compositions for treating or preventing inflammatory diseases such as psoriasis or multiple sclerosis are provided, comprising the step of delivering to the site of inflammation an anti-microtubule agent, or analogue or derivative thereof.

Assignees with Similar Patents

Angiotech International (19)
PG-TXL (12)
IPXMEDICAL, LLC (8)
ANGIODEVICE INTERNATIONAL (5)
Samyang (5)

Referenced by

Boston Scientific (38)
conextions (19)
CritiTech (18)
broncus medical (16)
Celgene (12)
dfb soria (7)
University of Utah (5)
SurModics (4)
resurge therapeutics (4)
ROCHE DIAGNOSTICS HEMATOLOGY, INC. (2)
Broncus Technologies (2)
COOK MEDICAL TECHNOLOGIES (2)
Cardiac Pacemakers (2)
Industrial Technology research Institute (2)
Covidien (2)
SWEET, RICHARD M. (2)
critltech (1)
Remon Medical Technologies (1)
Bristol-Myers Squibb (1)
Abbott Laboratories (1)
Omeros (1)
UNIVERSITY OF BRITISH COLUMBIA, THE (1)
Otago Innovation (1)
University of Kentucky Research Foundation (1)
dfb soria ll (1)

Tech Analysis

Class Subclass Type Reference Factor Citation Factor Strength Grant time Early grant (%)
514 365 Emerging Sustaining Seminal Medium Average 40.7